Current Report Filing (8-k)
November 09 2017 - 7:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 9, 2017
PhaseRx, Inc.
(Exact name of registrant as specified in
its charter)
Delaware
|
001-37772
|
20-4690620
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
410 W. Harrison Street, Suite 300
Seattle, Washington
|
98119
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including
area code:
(206) 805-6300
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
x
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
x
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
On November 9, 2017, PhaseRx, Inc. (the
“Company”) issued a press release announcing its financial results for the third fiscal quarter ended September 30,
2017. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
In accordance with General Instruction B.2
of Form 8-K, the information furnished pursuant to this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall
not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise be subject to the liabilities of that section, and such information shall not be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the
date hereof and regardless of any general incorporation language in such filing.
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits
* This exhibit is furnished pursuant to Item 2.02 and shall
not be deemed to be “filed.”
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
PhaseRx, Inc.
|
|
|
|
|
|
Date: November 9, 2017
|
By:
|
/s/ Robert W. Overell
|
|
|
|
Robert W. Overell, Ph.D.
|
|
|
|
Chief Executive Officer
|
|
PhaseRx (CE) (USOTC:PZRXQ)
Historical Stock Chart
From May 2024 to Jun 2024
PhaseRx (CE) (USOTC:PZRXQ)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about PhaseRx Inc (CE) (OTCMarkets): 0 recent articles
More Phaserx, Inc. News Articles